All Substitutes

Loading...

Disclaimer

Want to know more?
Read Our Editorial Policy

Did you find this information helpful?

    
REATIX KIT TABLET_1
REATIX KIT TABLET_2
REATIX KIT TABLET_3
REATIX KIT TABLET_1
39% Off

Reatix Kit Tablet

Prescription Required

Salt Composition : Atazanavir,emtricitabine,ritonavir,tenofovir Disoproxil Fumarate

Manufacturer : EMCURE PHARMACEUTICALS LTD

Origin of Medicine : India

MRP: ₹996
Price : ₹606
You Save : ₹390 (39%)

1 Tablet(s) In A Strip

Pincode
Delivery By -

Introduction to Reatix Kit Tablet

Reatix Kit tablet consists of the active substance called Atazanavir, Emtricitabine, Ritonavir, Tenofovir Disoproxil Fumarate. Atazanavir, Ritonavir is an antiviral medicine which belongs to the family called protease inhibitors. Emtricitabine, Tenofovir Disoproxil Fumarate is an antiretroviral medicine belonging to nucleotide reverse transcriptase inhibitor (NRTI). This medicine is used for HIV (human immunodeficiency virus) infection. It works by inhibiting the enzymes (HIV reverse transcriptase) which is important for virus replication. This medicine is not suggested for children under 12 years. 

Do not consume Reatix Kit tablet if you have experienced allergic reactions to Atazanavir, Emtricitabine, Ritonavir, Tenofovir Disoproxil Fumarate or any of its ingredients. During the Atazanavir, Emtricitabine, Ritonavir, and Tenofovir Disoproxil Fumarate tablet treatment, your doctor may periodically monitor your blood counts, bone mineral density, heart, liver, and kidney parameters to prevent serious complications. Report to your doctor if you have had a history of heart failure (PR prolongation), hypersensitivity (toxic skin eruptions, or Stevens-Johnson syndrome), pancreatitis, bone disease (osteoporosis), liver (chronic hepatitis B or C), or kidney problems. Inform your doctor if you are 65 years old. 

Patients consuming this medicine may develop immune reconstitution syndrome, diabetes mellitus, excessive body fat, and hyperbilirubinemia. Reatix Kit tablet should not be given to patients with existing kidney problems. Report to your physician if you are on a phosphate diet, as this medicine contains phosphate. If you have lactose intolerance, notify your doctor before starting the treatment. Report your doctor if you are planning to get pregnant or think you may be pregnant. Breastfeeding is not suggested due to the potential transmission of HIV. Use effective contraception to avoid transmission of HIV infection from patients

Uses of Reatix Kit Tablet

  • Treatment HIV infection

Therapeutic Effects of Reatix Kit Tablet

Atazanavir and Ritonavir inhibit the viral enzyme (protease). Emtricitabine and Tenofovir disoproxil fumarate inhibit the enzyme reverse transcriptase; inhibiting these enzymes blocks the multiplication of the virus and prevents the release of viral particles in the body to treat the HIV infection

Interaction of Reatix Kit Tablet with other drugs

Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional or vitamin supplements, and herbal products you take or have taken before the treatment. Certain medications may interact with Reatix Kit tablet and can cause undesirable side effects.

More Information about Reatix Kit Tablet

  • Store at a temperature not exceeding 30°C.
  • Keep away from moisture, heat, and light.
  • Do not freeze the medicine.
  • Keep out of the reach of pets and children.

How to consume Reatix Kit Tablet

Reatix Kit tablet are film-coated tablets. The usual recommended dosage of this medication is one tablet every day, without or with food. Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person. Do not chew, crush, dissolve or break the tablet.

Safety Advices for Reatix Kit Tablet

Image Not Available  

Pregnancy

  

Notify your healthcare professional if you are pregnant or planning to have a baby think you may be pregnant. Your physician will conduct regular tests to monitor the development of your child. Ask for suggestions before taking the Reatix Kit tablet.

Image Not Available  

Breast Feeding

  

It is unsafe to breastfeed if you are with HIV infection. Consult your doctor for more information about Reatix Kit tablet. 

Image Not Available  

Lungs

  

It is unknown whether Reatix Kit tablet is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Image Not Available  

Liver

  

Inform your physician about any underlying liver disorders before taking Reatix Kit tablet, as these drugs should be used with caution in liver disease patients. Your doctor may monitor your liver enzymes. Consult your physician before taking this medicine.

Image Not Available  

Alcohol

  

Do not consume alcohol while taking the Reatix Kit tablet, as this injection may cause drowsiness with alcohol.

Image Not Available  

Driving

  

Driving while taking Reatix Kit tablet is unsafe because this medicine might cause vision problems and tiredness, so avoid driving and operating machinery during this treatment.

Side Effects of Reatix Kit Tablet

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. 

Serious

  • Pancreas injury
  • Inflammation or infection
  • Lactic acidosis (excess lactic acid)
  • Autoimmune disorder

Common

  • Increased blood lipid level
  • Increased liver enzymes
  • Rashes
  • Weakness
  • Diarrhea
  • Dizziness
  • Joint pain
  • Sickness
  • Rash
  • Weakness

Word of Advice

Inform your doctor about your underlying infections. If you have advanced HIV (AIDS), you may develop signs of infection and inflammation or worsen the signs of an existing infection once treatment is started. Report your doctor for side effects. It is very mandatory to tell your medical professional if you are consuming other medicines that may damage your kidneys. 

Always consume the dose recommended by your doctor. Reatix Kit tablet does not reduce the risk of transferring on HIV to others through sexual contact or blood contamination. You must continue the medication to avoid this complication. Most patients experience asymptomatic increases in hyperbilirubinemia (increase in bilirubin).

FAQs

Q 1. What are the molecules present in Reatix Kit tablet?

Reatix Kit tablet contains the active ingredients of Atazanavir, Emtricitabine, Ritonavir and Tenofovir Disoproxil Fumarate.

Q 2. Can you consume alcohol while on treatment with Reatix Kit tablet?

No, it is not recommended to drink alcohol while on this treatment; it adds to the risk of liver injury. Reatix Kit tablet is associated with an increased risk of liver damage and impairment.

Q 3. What are the symptoms of lactic acidosis?

Unusual weakness, tiredness, muscle pain, trouble breathing, stomach pain, nausea, vomiting, dizziness, lightheadedness, irregular heartbeat, and feeling cold in your arms and legs are the most prominent symptoms of lactic acidosis.

Q 4. Who are cautious about the Reatix Kit tablet?

Patients with pancreatitis, bone condition, liver, and kidney condition should cautiously consume Reatix Kit tablets

Q 5. Should I still use protection even if we both have HIV infections?

Yes, it is mandatory to use effective contraception to prevent the transmission of HIV infection, even though both partners have HIV infection. This is because of the chance of having distinct viral strains or subtypes between partners, which increases the risk of superinfection or reinfection.

Fact Box of Reatix Kit Tablet

Molecule name: Atazanavir, Emtricitabine, Ritonavir, Tenofovir Disoproxil Fumarate

Therapeutic class: 

1. Antiviral 

2. Antiretrovirals

Pharmacological class:

1. Atazanavir + Ritonavir - Protease inhibitor

2. Emtricitabine + Tenofovir Disoproxil Fumarate - Nucleoside reverse transcriptase inhibitors (NRTIs)

Indications:  HIV Infection


 

References

  1. Cipla Ltd, US Food and Drug Administration, [ Revised on October 2017] [ Accessed on 18th May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/pepfar/206451PI.pdf
  2. KD Tripathi, Essentials of Medical Pharmacology, Antiviral drugs, 7th Edition, 2013, 809 - 810.
  3. Generics (UK) Limited, Electronic Medicines Compendium (EMC), [Revised on May 2022] [Accessed on 24th May 2023]   https://www.medicines.org.uk/emc/files/pil.9028.pdf.

Disclaimer

MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.